UNCY
Unicycive Therapeutics, Inc.
+0.04 (+0.84%)4.82USD254K成交股數134M市值–本益比(近四季)198.9股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | 675K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.8M | 1.6M | 3.0M | 1.8M | 2.2M | 5.3M | 3.0M | 4.9M | 6.8M | 3.4M | 2.3M | 3.0M |
| 銷售管理費用 | 7.4M | 6.8M | 4.4M | 5.2M | 5.8M | 4.0M | 3.2M | 2.5M | 2.4M | 479K | 193K | 62K |
| 營業利益 | −10.1M+27% | −8.4M-9% | −7.3M+17% | −7.0M-6% | −8.0M-13% | −9.3M+56% | −6.3M+45% | −7.4M+76% | −9.2M | −5.9M | −4.3M | −4.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | -622.5% |
| 稅後淨利 | −1.7M-402% | −12.8M-40% | −6.0M+47% | −6.4M-165% | 570K-103% | −21.5M+397% | −4.1M+7% | 9.9M-168% | −21.0M | −4.3M | −3.8M | −14.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | -2,159.3% |
| 稀釋 EPS | -0.06-88% | -0.54-82% | -0.33-28% | -0.52-65% | -0.50-18% | -3.08+2269% | -0.46+59% | -1.50+55% | -0.61 | -0.13 | -0.29 | -0.97 |
| 稀釋股數 | 26.9M | 23.9M | 18.1M | 12.3M | 12.4M | 6.7M | 8.9M | 9.4M | 34.9M | 32.6M | 15.2M | 15.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 44.2M | 37.4M | 42.7M | 22.3M | 19.8M | 26.1M | 32.3M | 41.8M | 48.9M | 14.3M | 18.8M | 24.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | 3.1M | 1.9M |
| 總資產 | 72.0M | 64.4M | 50.6M | 30.0M | 27.9M | 31.7M | 38.6M | 44.7M | 52.4M | 19.4M | 22.9M | 27.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 18.8M | 26.7M | 13.1M | 13.6M | 16.7M | 24.2M | 10.7M | 13.4M | 30.7M | 16.0M | 16.1M | 16.7M |
| 股東權益 | 53.3M | 37.7M | 37.5M | 16.4M | 11.3M | 7.4M | −27.9M | −14.8M | −24.5M | 3.4M | −19.4M | −15.1M |
| 負債比 | 26.0% | 41.5% | 25.9% | 45.2% | 59.7% | 76.5% | 27.8% | 29.9% | 58.5% | 82.3% | 70.2% | 61.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −6.2M | – | – | −8.9M+38% | – | – | – | −6.5M | – | – | −3.9M |
| 資本支出 | – | 8K | – | – | 16K | – | – | – | 6K | – | – | – |
| 自由現金流 | – | −6.2M | – | – | −8.9M+38% | – | – | – | −6.5M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | 200K |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −26.6M | –% | -1.67 | −31.3M |
| FY2024 | – | – | −36.7M | –% | -5.65 | −28.6M |
| FY2023 | 675K | -29.0% | −30.5M | -4,525.0% | -1.28 | −18.3M |
| FY2022 | 951K | – | −18.1M | -1,898.8% | -1.20 | −15.7M |
| FY2021 | – | – | −10.0M | –% | -0.86 | −5.8M |
| FY2020 | – | – | −2.3M | –% | – | – |